Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL) (Q73253020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

title

Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

stem cell transplantation

2 November 2019

main subject

1 reference

Primary systemic amyloidosis

inferred from title

1 reference

8

Litzow MR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

1

Gertz MA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

2

Lacy MQ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

6

Tefferi A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Gastineau DA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

Inwards DJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

Chen MG

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

Kyle RA

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

963-969

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11100275 AND SRC:MED&resulttype=core&format=json

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Allogeneic bone marrow transplantation for systemic AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Allogeneic bone marrow transplantation for AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Factors influencing platelet recovery after blood cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Autotransplants in multiple myeloma: pushing the envelope

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

1 reference

7 January 2021

Intensive Therapy in AL Amyloidosis and Light-Chain Deposition Disease

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Mobilized CD34 cells selected as autografts in patients with primary light‐chain amyloidosis: rationale and application

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021

Fatal cardiac failure after a single dose of doxorubicin in myeloma-associated cardiac amyloid

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1702643

7 January 2021